Peptinovo Biopharma
Steve Tokarz, Acting CEO, 30+ years of business and start-up experience. Founded Cantilever Investors Fund and Business Partners. Experienced C-level entrepreneur, fundraiser, and business developer. Launched several businesses in Masco Corp. Exited first company after $14 mil raise. Steve provides the business development and first-hand knowledge of how to commercialize new technologies and efficiently bring them to market. Steve will focus on developing the business framework, negotiating intellectual property rights, rounding out the team and raising funds for future growth.
Peptinovo Biopharma
1 followers
Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.